Search

You searched for "Thread"

743 results found

Medico-legal Forum (Botulinum toxin)

1 February 2017 | PMFA - Aesthetic Medicine, PMFA - Dermatology
The PMFA Journal and Hamilton Fraser Cosmetic Insurance have teamed up to provide a series of articles that will give examples of claims that occur from different procedures. The case in question In 2014 a patient underwent treatment using abobotulinumtoxinA...

Auricular reconstruction: star-pattern reconstruction

30 March 2022 | | PMFA - Facial Plastic Surgery
We describe our approach to straightforward reconstruction of the peripheral auricle using the established star-pattern design. Skin malignancies developing on the auricle continue to be regarded as high-risk lesions due to their propensity to recur and for lymphatic spread. Greater...

How I Do It - Anti-ageing focus: Effectively treating vascular and pigmented lesions with no associated downtime

2 June 2021 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
More patients are demanding treatments that require little to no downtime and that have very little noticeable side-effects. It is understandable why patient seek this from a non-surgical aesthetic treatment; however, it can be particularly challenging when looking to treat...

Facial nerve palsy and Facial Palsy UK

1 June 2015 | | PMFA - Aesthetic Medicine, PMFA - Facial Plastic Surgery
The term facial palsy is most commonly used to describe a paralytic lower motor neurone (LMN) dysfunction of the facial nerve. Upper motor neurone facial palsy, for example due to strokes and intra-cranial tumours, spares the forehead muscles and will...

A short overview of the evolution of botulinum toxin type A formulations

1 June 2023 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Botulinum toxin type A for the treatment of allergic & idiopathic rhinitis: The Aller-Tox™ method

17 April 2025 | | PMFA - Maxillofacial Surgery, PMFA - Aesthetic Medicine
Hay fever provides a significant burden on the NHS, according to NHS data, approximately 20% of UK residents are hay fever sufferers. Around one fifth of these patients with allergies struggle with the fear of a possible asthma attack [1]....

How I Do It - Treating acne and acne scarring in all skin types

30 March 2022 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
I use the Aerolase Neo Elite, which is a 650 microsecond, 1064 NdYag laser, to treat inflammatory acne, post-inflammatory hyperpigmentation, post-inflammatory erythema, and rolling acne scars in skin types I-VI. This laser has revolutionised the way I treat acne in...

How I Do It - Using Nd:Yag laser for correction of vascular anomalies

14 November 2023 | | PMFA - Dermatology, PMFA - General Plastic Surgery, PMFA - Facial Plastic Surgery
Vascular anomalies are the most common lesions that can often lead to disfigurement of a child's appearance. Due to the complexity of diagnosis and individual specialists’ understanding of their pathological process, these young patients often undergo many unnecessary tests and...

Photorejuvenation: Light & Bright™ treatment for enhanced skin quality

4 October 2024 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Improving skin quality has emerged as a significant trend in recent years, driven by the synergy between at-home skincare routines and diverse aesthetic procedures administered by medical professionals. With sun-induced skin damage manifesting early in life, there’s a surging demand...

Cautions, contraindications and complications in aesthetics

5 August 2020 | | PMFA - Aesthetic Medicine
All aesthetic practitioners will face complications during their career. It is therefore vital to be prepared. Dr Nestor Demosthenous provides a comprehensive guide to potential complications when treating patients with fillers. A complication during or following a treatment carried out...

Treatment of facial subcutaneous fibrosis with hyaluronic acid

12 October 2021 | | PMFA - CPD
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Systemic sclerosis (SSc) is a rare and chronic connective tissue disease (CTD)...

Debate: cannulas vs. needles - Needles

1 December 2014 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
It is generally agreed that the choice of cannula or needle is site and material dependent, but the injector‘s comfort and skill in creating a desired aesthetic result is also important. The two most important considerations are the aesthetic outcome...